TDC
IBIO icon

Thompson Davis & Co’s iBio IBIO Stock Holding History

Thompson Davis & Co’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Hold
0
– – – 1182
2015
Q2 		– Hold
0
– – – 1214
2014
Q4 		– Sell
-1
Closed -$3K – 1204
2014
Q3 		$3K Buy
+1
New +$2.44K ﹤0.01% 994

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
PAMG
Patton Albertson Miller Group Chattanooga, Tennessee $1B AUM 40.9% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Thompson Davis & Co's IBIO Position: Q3 2015 in Review

Thompson Davis & Co held its iBio (IBIO) position steady in Q3 2015 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Thompson Davis & Co first reported a position in IBIO in Q3 2014 and has held it in 1 quarter since. The position peaked at $3K in Q3 2014. 14 funds tracked by Wall St. Rank hold IBIO as of Q3 2015.

  • Thompson Davis & Co held 0 shares of iBio worth $0 as of Q3 2015.
  • Thompson Davis & Co left its iBio share count unchanged in Q3 2015.
  • iBio made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2015, its #1182 holding.
  • Thompson Davis & Co first reported a position in iBio in Q3 2014 and has held it in 1 quarter since.
  • Thompson Davis & Co's iBio position peaked at $3K in Q3 2014.
  • 14 funds tracked by Wall St. Rank held iBio as of Q3 2015.

Based on Thompson Davis & Co's 13F filing for Q3 2015, filed 30 Oct 2015.